Advances in prevention and treatment of MAC.
Cheng
B
B
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D017963:Azithromycin / Q000008:administration & dosage / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D017291:Clarithromycin / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D002991:Clofazimine / Q000008:administration & dosage / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy / Q000517:prevention & control*; D017828:Rifabutin / Q000008:administration & dosage / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use
D017828:Rifabutin; D017963:Azithromycin; D004977:Ethambutol; D002991:Clofazimine; D017291:Clarithromycin; D012293:Rifampin